Charles Schwab Investment Management Inc Dynavax Technologies Corp Transaction History
Charles Schwab Investment Management Inc
- $557 Billion
- Q2 2025
A detailed history of Charles Schwab Investment Management Inc transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 998,235 shares of DVAX stock, worth $10.1 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
998,235
Previous 1,157,993
13.8%
Holding current value
$10.1 Million
Previous $15 Million
34.07%
% of portfolio
0.0%
Previous 0.0%
Shares
33 transactions
Others Institutions Holding DVAX
# of Institutions
294Shares Held
120MCall Options Held
294KPut Options Held
77.6K-
Black Rock Inc. New York, NY21.9MShares$221 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT17.8MShares$179 Million6.26% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.43MShares$84.9 Million0.0% of portfolio
-
State Street Corp Boston, MA6.4MShares$64.4 Million0.0% of portfolio
-
Chicago Capital, LLC4.31MShares$43.4 Million1.06% of portfolio
About DYNAVAX TECHNOLOGIES CORP
- Ticker DVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 126,474,000
- Market Cap $1.27B
- Description
- Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...